Skip to content

Application of ultrasound guided subcostal approach quadratus lumbar muscle block combined with general anesthesia in multi-level lumbar spine surgery

Application of ultrasound guided subcostal approach quadratus lumbar muscle block combined with general anesthesia in multi-level lumbar spine surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042601
Enrollment
Unknown
Registered
2021-01-24
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disease

Interventions

quadratus lumbar muscle block group:0.375% ropivacaine 0.3ml/kg
placebo control group:the equal dose normal saline

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Volunteer to participate in this trial and sign an informed consent instruction; 2) Age 40~70 years old; 3) Elective multi-segment lumbar spine surgery; 4) American Association of Anesthesiologists (ASA) physical condition classification I to III.

Exclusion criteria

Exclusion criteria: 1) Any cerebrovascular accident occurred within 3 months, such as stroke, transient ischemic attack (TIA), etc.; 2) History of cardiac insufficiency or echocardiogram showing EF<30%; severe sinus bradycardia (HR<50bpm); II or III degree atrioventricular block; active heart disease (acute myocardial infarction, unstable angina, etc.). 3) Dementia state or severe cognitive dysfunction; 4) Poor surgical anesthesia experience; 5) Abnormalities of nervous system, endocrine system, liver and kidney function; 6) There is a history of allergy to the drug being studied. 7) Past medical history of chronic pain; 8) History of opioid abuse or addiction.

Design outcomes

Primary

MeasureTime frame
postoperative pain scores;the first compression time of the electronic analgesic pump;infection;get out of bed time;Intestinal ventilation time;in-hospital time;

Secondary

MeasureTime frame
Total opioid consumption;the compression times of electronic analgesia pump;blood pressure and heart rate;infusion and transfusion;blood loss;urine volume;Nausea and vomiting;the duration time of surgery;the duration time of anesthesia;the time of awakening ;agitation of awakening period;Hypoxic saturation;delirium of Awakening period;

Countries

China

Contacts

Public ContactZuo Chun Long

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University

chunlon1988@163.com+86 18356000210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026